In-depth proteomics of ovarian cancer ascites: Combining shotgun proteomics and selected reaction monitoring mass spectrometry

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2286-2299

  Elschenbroich, Sarah ^a,b   Ignatchenko, Vladimir ^a   Clarke, Blaise ^f   Kalloger, Steve E ^c   Boutros, Paul C ^d   Gramolini, Anthony O ^f   Shaw, Patricia ^a   Jurisica, Igor ^a,e,f   Kislinger, Thomas ^a,e,f,g  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^e Campbell Family Institute for Cancer Research   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Tower 101 ^*  (Canada)

Author keywords

ascites; MudPIT; OFFGEL; ovarian cancer; proteomics; SRM MS

Indexed keywords

MESSENGER RNA;

ARTICLE; ASCITES; ASCITES FLUID; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS;

ASCITES; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; OVARIAN NEOPLASMS; PROTEINS; PROTEOMICS;

EID: 79955865815     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr1011087     Document Type: Article

References (87)

1. Sankaranarayanan, R.; Ferlay, J. Worldwide burden of gynaecological cancer: the size of the problem Best Pract. Res. 2006, 20 (2) 207-25 (Pubitemid 43380597)
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics CA: Cancer J. Clinicians 2009, 59 (4) 225-49
3. Shaw, P. A.; Rouzbahman, M.; Pizer, E. S.; Pintilie, M.; Begley, H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers Mod. Pathol. 2009, 22 (9) 1133-8
4. Cannistra, S. A. Cancer of the ovary New Engl. J. Med. 2004, 351 (24) 2519-29
5. Hanash, S. M.; Pitteri, S. J.; Faca, V. M. Mining the plasma proteome for cancer biomarkers Nature 2008, 452 (7187) 571-9 (Pubitemid 351483371)
6. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-83 (Pubitemid 44215392)
7. Sturgeon, C. M.; Duffy, M. J.; Stenman, U.-H.; Lilja, H.; Brünner, N.; Chan, D. W.; Babaian, R.; Bast, R. C., Jr.; Dowell, B.; Esteva, F. J.; Haglund, C.; Harbeck, N.; Hayes, D. F.; Holten-Andersen, M.; Klee, G. G.; Lamerz, R.; Looijenga, L. H.; Molina, R.; Nielsen, H. J.; Rittenhouse, H.; Semjonow, A.; Shih, I. M.; Sibley, P.; Sölétormos, G.; Stephan, C.; Sokoll, L.; Hoffman, B. R.; Diamandis, E. P. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Clin. Chem. 2008, 54 (12) 11-79
8. Kobel, M.; Kalloger, S. E.; Boyd, N.; McKinney, S.; Mehl, E.; Palmer, C.; Leung, S.; Bowen, N. J.; Ionescu, D. N.; Rajput, A.; Prentice, L. M.; Miller, D.; Santos, J.; Swenerton, K.; Gilks, C. B.; Huntsman, D. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med. 2008, 5 (12) e232
9. Nolen, B.; Marrangoni, A.; Velikokhatnaya, L.; Prosser, D.; Winans, M.; Gorelik, E.; Lokshin, A. A serum based analysis of ovarian epithelial tumorigenesis Gynecologic Oncol. 2009, 112 (1) 47-54
10. Anderson, G. L.; McIntosh, M.; Wu, L.; Barnett, M.; Goodman, G.; Thorpe, J. D.; Bergan, L.; Thornquist, M. D.; Scholler, N.; Kim, N.; O'Briant, K.; Drescher, C.; Urban, N. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study J. Natl. Cancer Inst. 2010, 102 (1) 26-38
11. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-41
12. Huttenhain, R.; Malmstrom, J.; Picotti, P.; Aebersold, R. Perspectives of targeted mass spectrometry for protein biomarker verification Curr. Opin. Chem. Biol. 2009, 13 (5-6) 518-25
13. Gerber, S. A.; Rush, J.; Stemman, O.; Kirschner, M. W.; Gygi, S. P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (12) 6940-5 (Pubitemid 36706372)
14. Keshishian, H.; Addona, T.; Burgess, M.; Mani, D. R.; Shi, X.; Kuhn, E.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2009, 8 (10) 2339-49
15. Kuhn, E.; Addona, T.; Keshishian, H.; Burgess, M.; Mani, D. R.; Lee, R. T.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin. Chem. 2009, 55 (6) 1108-17
16. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-77
17. Picotti, P.; Bodenmiller, B.; Mueller, L. N.; Domon, B.; Aebersold, R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics Cell 2009, 138 (4) 795-806
18. Zhang, Z.; Bast, R. C., Jr.; Yu, Y.; Li, J.; Sokoll, L. J.; Rai, A. J.; Rosenzweig, J. M.; Cameron, B.; Wang, Y. Y.; Meng, X. Y.; Berchuck, A.; Van Haaften-Day, C.; Hacker, N. F.; de Bruijn, H. W.; van der Zee, A. G.; Jacobs, I. J.; Fung, E. T.; Chan, D. W. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res. 2004, 64 (16) 5882-90 (Pubitemid 39095590)
19. Smalley, D. M.; Sheman, N. E.; Nelson, K.; Theodorescu, D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer J. Proteome Res. 2008, 7 (5) 2088-96
20. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J. A.; Wong, D. T. Salivary proteomics for oral cancer biomarker discovery Clin. Cancer Res. 2008, 14 (19) 6246-52
21. Davidson, B. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature Anal. Cell Pathol. 2001, 23 (3-4) 107-28 (Pubitemid 34621775)
22. Faca, V. M.; Ventura, A. P.; Fitzgibbon, M. P.; Pereira-Faca, S. R.; Pitteri, S. J.; Green, A. E.; Ireton, R. C.; Zhang, Q.; Wang, H.; O'Briant, K. C.; Drescher, C. W.; Schummer, M.; McIntosh, M. W.; Knudsen, B. S.; Hanash, S. M. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains PloS One 2008, 3 (6) e2425
23. Gortzak-Uzan, L.; Ignatchenko, A.; Evangelou, A. I.; Agochiya, M.; Brown, K. A.; St Onge, P.; Kireeva, I.; Schmitt-Ulms, G.; Brown, T. J.; Murphy, J.; Rosen, B.; Shaw, P.; Jurisica, I.; Kislinger, T. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers J. Proteome Res. 2008, 7 (1) 339-51 (Pubitemid 351171148)
24. Kuk, C.; Kulasingam, V.; Gunawardana, C. G.; Smith, C. R.; Batruch, I.; Diamandis, E. P. Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers Mol. Cell. Proteomics 2009, 8 (4) 661-9
25. Amon, L. M.; Law, W.; Fitzgibbon, M. P.; Gross, J. A.; O'Briant, K.; Peterson, A.; Drescher, C.; Martin, D. B.; McIntosh, M. Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer PloS One 2010, 5 (6) e11137
26. Taylor, P.; Nielsen, P. A.; Trelle, M. B.; Horning, O. B.; Andersen, M. B.; Vorm, O.; Moran, M. F.; Kislinger, T. Automated 2D peptide separation on a 1D nano-LC-MS system J. Proteome Res. 2009, 8 (3) 1610-6
27. Licklider, L. J.; Thoreen, C. C.; Peng, J.; Gygi, S. P. Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column Anal. Chem. 2002, 74 (13) 3076-83 (Pubitemid 34755220)
28. Sodek, K. L.; Evangelou, A. I.; Ignatchenko, A.; Agochiya, M.; Brown, T. J.; Ringuette, M. J.; Jurisica, I.; Kislinger, T. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT) Mol. Biosyst. 2008, 4 (7) 762-73 (Pubitemid 351871749)
29. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92 (Pubitemid 35215372)
30. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-58 (Pubitemid 37082259)
31. Drake, R. R.; Elschenbroich, S.; Lopez-Perez, O.; Kim, Y.; Ignatchenko, V.; Ignatchenko, A.; Nyalwidhe, J. O.; Basu, G.; Wilkins, C. E.; Gjurich, B.; Lance, R. S.; Semmes, O. J.; Medin, J. A.; Kislinger, T. In-depth proteomic analyses of direct expressed prostatic secretions J. Proteome Res. 2010, 9 (5) 2109-16
32. Gunawardana, C. G.; Kuk, C.; Smith, C. R.; Batruch, I.; Soosaipillai, A.; Diamandis, E. P. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer J. Proteome Res. 2009, 8 (10) 4705-13
33. Tothill, R. W.; Tinker, A. V.; George, J.; Brown, R.; Fox, S. B.; Lade, S.; Johnson, D. S.; Trivett, M. K.; Etemadmoghadam, D.; Locandro, B.; Traficante, N.; Fereday, S.; Hung, J. A.; Chiew, Y. E.; Haviv, I.; Gertig, D.; DeFazio, A.; Bowtell, D. D. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin. Cancer Res. 2008, 14 (16) 5198-208
34. Irizarry, R. A.; Bolstad, B. M.; Collin, F.; Cope, L. M.; Hobbs, B.; Speed, T. P. Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res. 2003, 31 (4) e15
35. Dai, M.; Wang, P.; Boyd, A. D.; Kostov, G.; Athey, B.; Jones, E. G.; Bunney, W. E.; Myers, R. M.; Speed, T. P.; Akil, H.; Watson, S. J.; Meng, F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data Nucleic Acids Res. 2005, 33 (20) e175
36. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-8
37. Han, B.; Higgs, R. E. Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers Brief. Funct. Genomics Proteomics 2008, 7 (5) 340-54
38. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
39. Drake, R. R.; White, K. Y.; Fuller, T. W.; Igwe, E.; Clements, M. A.; Nyalwidhe, J. O.; Given, R. W.; Lance, R. S.; Semmes, O. J. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease J. Proteomics 2009, 72 (6) 907-17
40. Sedlaczek, P.; Frydecka, I.; Gabrys, M.; Van Dalen, A.; Einarsson, R.; Harlozinska, A. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma Cancer 2002, 95 (9) 1886-93 (Pubitemid 35222168)
41. Zhang, H.; Liu, Q.; Zimmerman, L. J.; Ham, A. J.; Slebos, R. J. C.; Rahman, J.; Kikuchi, T.; Massion, P. P.; Carbone, D. P.; Billheimer, D.; Liebler, D. C. Methods for Peptide and Protein Quantitation by Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry. Mol. Cell. Proteomics 2011, not supplied.
42. Elschenbroich, S.; Ignatchenko, V.; Sharma, P.; Schmitt-Ulms, G.; Gramolini, A. O.; Kislinger, T. Peptide separations by on-line MudPIT compared to isoelectric focusing in an off-gel format: application to a membrane-enriched fraction from C2C12 mouse skeletal muscle cells J. Proteome Res. 2009, 8 (10) 4860-9
43. Drabovich, A. P.; Diamandis, E. P. Combinatorial Peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins J. Proteome Res. 2010, 9 (3) 1236-45
44. Liu, H.; Sadygov, R. G.; Yates, J. R., 3rd A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-201 (Pubitemid 38943698)
45. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9 (21) 4997-5000
46. Fusaro, V. A.; Mani, D. R.; Mesirov, J. P.; Carr, S. A. Prediction of high-responding peptides for targeted protein assays by mass spectrometry Nat. Biotechnol. 2009, 27 (2) 190-8
47. Mallick, P.; Schirle, M.; Chen, S. S.; Flory, M. R.; Lee, H.; Martin, D.; Ranish, J.; Raught, B.; Schmitt, R.; Werner, T.; Kuster, B.; Aebersold, R. Computational prediction of proteotypic peptides for quantitative proteomics Nat. Biotechnol. 2007, 25 (1) 125-31 (Pubitemid 46098780)
48. Deutsch, E. W.; Lam, H.; Aebersold, R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows EMBO Rep. 2008, 9 (5) 429-34 (Pubitemid 351627279)
49. Mead, J. A.; Bianco, L.; Ottone, V.; Barton, C.; Kay, R. G.; Lilley, K. S.; Bond, N. J.; Bessant, C. MRMaid, the web-based tool for designing multiple reaction monitoring (MRM) transitions Mol. Cell. Proteomics 2009, 8 (4) 696-705
50. Sherwood, C. A.; Eastham, A.; Lee, L. W.; Peterson, A.; Eng, J. K.; Shteynberg, D.; Mendoza, L.; Deutsch, E. W.; Risler, J.; Tasman, N.; Aebersold, R.; Lam, H.; Martin, D. B. MaRiMba: a software application for spectral library-based MRM transition list assembly J. Proteome Res. 2009, 8 (10) 4396-405
51. Prakash, A.; Tomazela, D. M.; Frewen, B.; Maclean, B.; Merrihew, G.; Peterman, S.; Maccoss, M. J. Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development J. Proteome Res. 2009, 8 (6) 2733-9
52. Sherwood, C. A.; Eastham, A.; Lee, L. W.; Risler, J.; Vitek, O.; Martin, D. B. Correlation between y-type ions observed in ion trap and triple quadrupole mass spectrometers J. Proteome Res. 2009, 8 (9) 4243-51
53. Frewen, B. E.; Merrihew, G. E.; Wu, C. C.; Noble, W. S.; MacCoss, M. J. Analysis of peptide MS/MS spectra from large-scale proteomics experiments using spectrum libraries Anal. Chem. 2006, 78 (16) 5678-84 (Pubitemid 44265027)
54. Fortin, T.; Salvador, A.; Charrier, J. P.; Lenz, C.; Lacoux, X.; Morla, A.; Choquet-Kastylevsky, G.; Lemoine, J. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests Mol. Cell. Proteomics 2009, 8 (5) 1006-15
55. Huttlin, E. L.; Chen, X.; Barrett-Wilt, G. A.; Hegeman, A. D.; Halberg, R. B.; Harms, A. C.; Newton, M. A.; Dove, W. F.; Sussman, M. R. Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (40) 17235-40
56. Rangiah, K.; Tippornwong, M.; Sangar, V.; Austin, D.; Tetreault, M. P.; Rustgi, A. K.; Blair, I. A.; Yu, K. H. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer J. Proteome Res. 2009, 8 (11) 5153-64
57. Shah, S. J.; Yu, K. H.; Sangar, V.; Parry, S. I.; Blair, I. A. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry J. Proteome Res. 2009, 8 (5) 2407-17
58. Whiteaker, J. R.; Zhang, H.; Zhao, L.; Wang, P.; Kelly-Spratt, K. S.; Ivey, R. G.; Piening, B. D.; Feng, L. C.; Kasarda, E.; Gurley, K. E.; Eng, J. K.; Chodosh, L. A.; Kemp, C. J.; McIntosh, M. W.; Paulovich, A. G. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J. Proteome Res.h 2007, 6 (10) 3962-75 (Pubitemid 350032560)
59. Campbell, J.; Rezai, T.; Prakash, A.; Krastins, B.; Dayon, L.; Ward, M.; Robinson, S.; Lopez, M. Evaluation of absolute peptide quantitation strategies using selected reaction monitoring Proteomics 2011, 11 (6) 1148-52
60. Cima, I.; Schiess, R.; Wild, P.; Kaelin, M.; Schuffler, P.; Lange, V.; Picotti, P.; Ossola, R.; Templeton, A.; Schubert, O.; Fuchs, T.; Leippold, T.; Wyler, S.; Zehetner, J.; Jochum, W.; Buhmann, J.; Cerny, T.; Moch, H.; Gillessen, S.; Aebersold, R.; Krek, W. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 2010, not supplied.
61. Uhlen, M.; Bjorling, E.; Agaton, C.; Szigyarto, C. A.; Amini, B.; Andersen, E.; Andersson, A. C.; Angelidou, P.; Asplund, A.; Asplund, C.; Berglund, L.; Bergstrom, K.; Brumer, H.; Cerjan, D.; Ekstrom, M.; Elobeid, A.; Eriksson, C.; Fagerberg, L.; Falk, R.; Fall, J.; Forsberg, M.; Bjorklund, M. G.; Gumbel, K.; Halimi, A.; Hallin, I.; Hamsten, C.; Hansson, M.; Hedhammar, M.; Hercules, G.; Kampf, C.; Larsson, K.; Lindskog, M.; Lodewyckx, W.; Lund, J.; Lundeberg, J.; Magnusson, K.; Malm, E.; Nilsson, P.; Odling, J.; Oksvold, P.; Olsson, I.; Oster, E.; Ottosson, J.; Paavilainen, L.; Persson, A.; Rimini, R.; Rockberg, J.; Runeson, M.; Sivertsson, A.; Skollermo, A.; Steen, J.; Stenvall, M.; Sterky, F.; Stromberg, S.; Sundberg, M.; Tegel, H.; Tourle, S.; Wahlund, E.; Walden, A.; Wan, J.; Wernerus, H.; Westberg, J.; Wester, K.; Wrethagen, U.; Xu, L. L.; Hober, S.; Ponten, F. A human protein atlas for normal and cancer tissues based on antibody proteomics Mol. Cell. Proteomics 2005, 4 (12) 1920-32 (Pubitemid 41830186)
62. Allred, D. C.; Harvey, J. M.; Berardo, M.; Clark, G. M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod. Pathol. 1998, 11 (2) 155-68 (Pubitemid 28144151)
63. Hassan, R.; Ho, M. Mesothelin targeted cancer immunotherapy Eur. J. Cancer 2008, 44 (1) 46-53 (Pubitemid 350262830)
64. Argani, P.; Iacobuzio-Donahue, C.; Ryu, B.; Rosty, C.; Goggins, M.; Wilentz, R. E.; Murugesan, S. R.; Leach, S. D.; Jaffee, E.; Yeo, C. J.; Cameron, J. L.; Kern, S. E.; Hruban, R. H. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) Clin. Cancer Res. 2001, 7 (12) 3862-8 (Pubitemid 34044602)
65. Hassan, R.; Kreitman, R. J.; Pastan, I.; Willingham, M. C. Localization of mesothelin in epithelial ovarian cancer Appl. Immunohistochem. Mol. Morphol. 2005, 13 (3) 243-7 (Pubitemid 41209017)
66. Ordonez, N. G. Value of mesothelin immunostaining in the diagnosis of mesothelioma Mod. Pathol. 2003, 16 (3) 192-7 (Pubitemid 36337423)
67. Ordonez, N. G. Application of mesothelin immunostaining in tumor diagnosis Am. J. Surg. Pathol. 2003, 27 (11) 1418-28 (Pubitemid 37315193)
68. Rump, A.; Morikawa, Y.; Tanaka, M.; Minami, S.; Umesaki, N.; Takeuchi, M.; Miyajima, A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion J. Biol. Chem. 2004, 279 (10) 9190-8 (Pubitemid 38295982)
69. Warburg, O. On the origin of cancer cells Science 1956, 123 (3191) 309-14
70. Altenberg, B.; Greulich, K. O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes Genomics 2004, 84 (6) 1014-20 (Pubitemid 39469126)
71. Jurica, M. S.; Mesecar, A.; Heath, P. J.; Shi, W.; Nowak, T.; Stoddard, B. L. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate Structure 1998, 6 (2) 195-210 (Pubitemid 28153883)
72. Dombrauckas, J. D.; Santarsiero, B. D.; Mesecar, A. D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis Biochemistry 2005, 44 (27) 9417-29 (Pubitemid 40962040)
73. Mazurek, S.; Boschek, C. B.; Hugo, F.; Eigenbrodt, E. Pyruvate kinase type M2 and its role in tumor growth and spreading Semin. Cancer Biol. 2005, 15 (4) 300-8 (Pubitemid 41058775)
74. Christofk, H. R.; Vander Heiden, M. G.; Harris, M. H.; Ramanathan, A.; Gerszten, R. E.; Wei, R.; Fleming, M. D.; Schreiber, S. L.; Cantley, L. C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 2008, 452 (7184) 230-3 (Pubitemid 351380249)
75. Cerwenka, H.; Aigner, R.; Bacher, H.; Werkgartner, G.; el-Shabrawi, A.; Quehenberger, F.; Mischinger, H. J. TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions Anticancer Res. 1999, 19 (1B) 849-51 (Pubitemid 29168343)
76. Luftner, D.; Mesterharm, J.; Akrivakis, C.; Geppert, R.; Petrides, P. E.; Wernecke, K. D.; Possinger, K. Tumor type M2 pyruvate kinase expression in advanced breast cancer Anticancer Res. 2000, 20 (6D) 5077-82 (Pubitemid 32319084)
77. DeSouza, L. V.; Taylor, A. M.; Li, W.; Minkoff, M. S.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues J. Proteome Res. 2008, 7 (8) 3525-34
78. Hardt, P. D.; Mazurek, S.; Toepler, M.; Schlierbach, P.; Bretzel, R. G.; Eigenbrodt, E.; Kloer, H. U. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer Br. J. Cancer 2004, 91 (5) 980-4 (Pubitemid 39273794)
79. Schulze, G. The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer Anticancer Res. 2000, 20 (6D) 4961-4 (Pubitemid 32319059)
80. Vander Heiden, M. G.; Locasale, J. W.; Swanson, K. D.; Sharfi, H.; Heffron, G. J.; Amador-Noguez, D.; Christofk, H. R.; Wagner, G.; Rabinowitz, J. D.; Asara, J. M.; Cantley, L. C. Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 2010, 329 (5998) 1492-9
81. Sirover, M. A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochim. Biophys. Acta 1999, 1432 (2) 159-84 (Pubitemid 29304525)
82. Sirover, M. A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells J. Cell. Biochem. 2005, 95 (1) 45-52 (Pubitemid 41420214)
83. Colell, A.; Green, D. R.; Ricci, J. E. Novel roles for GAPDH in cell death and carcinogenesis Cell Death and Differ. 2009, 16 (12) 1573-81
84. Epner, D. E.; Coffey, D. S. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue Prostate 1996, 28 (6) 372-8 (Pubitemid 26187721)
85. Lavallard, V. J.; Pradelli, L. A.; Paul, A.; Beneteau, M.; Jacquel, A.; Auberger, P.; Ricci, J. E. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells Cancer Res. 2009, 69 (7) 3013-20
86. Revillion, F.; Pawlowski, V.; Hornez, L.; Peyrat, J. P. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer Eur. J. Cancer 2000, 36 (8) 1038-42 (Pubitemid 30316430)
87. Zhou, Y.; Yi, X.; Stoffer, J. B.; Bonafe, N.; Gilmore-Hebert, M.; McAlpine, J.; Chambers, S. K. The multifunctional protein glyceraldehyde-3- phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer Mol. Cancer Res. 2008, 6 (8) 1375-84